Related references
Note: Only part of the references are listed.New promising molecular targets in head and neck squamous cell carcinoma
Julie E. Bauman et al.
CURRENT OPINION IN ONCOLOGY (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells
Melike Mut et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer
Stefan Uhlmann et al.
MOLECULAR SYSTEMS BIOLOGY (2012)
MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression
Xiangjun Kong et al.
PLOS ONE (2012)
Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
Yuh Baba et al.
JOURNAL OF ONCOLOGY (2012)
miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling Pathways
Okay Saydam et al.
CANCER RESEARCH (2011)
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer
Ranee Mehra et al.
DRUG RESISTANCE UPDATES (2011)
Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7
Jason E. Duex et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The RNA-binding Protein HuR Opposes the Repression of ERBB-2 Gene Expression by MicroRNA miR-331-3p in Prostate Cancer Cells
Michael R. Epis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Liposomal Delivery of MicroRNA-7-Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
Kammei Rai et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Eric Huntzinger et al.
NATURE REVIEWS GENETICS (2011)
microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling
Kyung Min Lee et al.
RADIOTHERAPY AND ONCOLOGY (2011)
MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
Lu Jiang et al.
BIOCHEMICAL JOURNAL (2010)
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Deric L. Wheeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma
Geoffrey Childs et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Predicting microRNA targets in time-series microarray experiments via functional data analysis
Brian J. Parker et al.
BMC BIOINFORMATICS (2009)
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
Tanguy Y. Seiwert et al.
CANCER RESEARCH (2009)
Identification of Biomarkers in Human Head and Neck Tumor Cell Lines That Predict For In Vitro Sensitivity to Gefitinib
D. Mark Hickinson et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2009)
Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
Rebecca J. Webster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma
Benjamin Kefas et al.
CANCER RESEARCH (2008)
MicroRNA-7, a Homeobox D10 Target, Inhibits p21-Activated Kinase 1 and Regulates Its Functions
Sirigiri Divijendra Natha Reddy et al.
CANCER RESEARCH (2008)
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Sharon Barr et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue
Thian-Sze Wong et al.
CLINICAL CANCER RESEARCH (2008)
EGFR inhibition as a therapy for head and neck squamous cell carcinoma
Judith Loeffler-Ragg et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
MicroRNA alterations in head and neck squamous cell carcinomal
Steven S. Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines
David R. Emlet et al.
MOLECULAR CANCER THERAPEUTICS (2007)
MicroRNA expression profiles in head and neck cancer cell lines
Nham Tran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
MicroRNAs and endocrine biology
TL Cuellar et al.
JOURNAL OF ENDOCRINOLOGY (2005)
CK2 binds, phosphorylates, and regulates its pivotal substrate Cdc37, an Hsp90-cochaperone
Y Miyata et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
G Di Maira et al.
CELL DEATH AND DIFFERENTIATION (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells
S Tanida et al.
GASTROENTEROLOGY (2004)
Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines
LH Kalish et al.
CLINICAL CANCER RESEARCH (2004)
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck
D Soulieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A PCR primer bank for quantitative gene expression analysis
XW Wang et al.
NUCLEIC ACIDS RESEARCH (2003)
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
EEW Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
